Fenton RG - Search Results

1

Cellular and molecular studies in the treatment of murine renal cancer.

Wiltrout RH, Gregorio TA, Fenton RG, Longo DL, Ghosh P, Murphy WJ, Komschlies KL. Wiltrout RH, et al. Among authors: fenton rg. Semin Oncol. 1995 Feb;22(1):9-16. Semin Oncol. 1995. PMID: 7855624 Review.

2

Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.

Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH. Sayers TJ, et al. Among authors: fenton rg. J Immunol. 1998 Oct 15;161(8):3957-65. J Immunol. 1998. PMID: 9780164

3

A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2.

Holmund JT, Kopp WC, Wiltrout RH, Longo DL, Urba WJ, Janik JE, Sznol M, Conlon KC, Fenton RG, Hornung R, et al. Holmund JT, et al. Among authors: fenton rg. J Natl Cancer Inst. 1995 Jan 18;87(2):134-6. doi: 10.1093/jnci/87.2.134. J Natl Cancer Inst. 1995. PMID: 7707385 Clinical Trial. No abstract available.

4

Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2.

Curti BD, Longo DL, Ochoa AC, Conlon KC, Smith JW 2nd, Alvord WG, Creekmore SP, Fenton RG, Gause BL, Holmlund J, et al. Curti BD, et al. Among authors: fenton rg. J Clin Oncol. 1993 Apr;11(4):652-60. doi: 10.1200/JCO.1993.11.4.652. J Clin Oncol. 1993. PMID: 8257476 Clinical Trial.

5

Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.

Taub DD, Murphy WJ, Asai O, Fenton RG, Peltz G, Key ML, Turcovski-Corrales S, Longo DL. Taub DD, et al. Among authors: fenton rg. J Immunol. 1997 Mar 15;158(6):2745-55. J Immunol. 1997. PMID: 9058809

6

T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.

Siders WM, Wright PW, Hixon JA, Alvord WG, Back TC, Wiltrout RH, Fenton RG. Siders WM, et al. Among authors: fenton rg. J Immunol. 1998 Jun 1;160(11):5465-74. J Immunol. 1998. PMID: 9605149

7

Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes.

Fenton RG, Taub DD, Kwak LW, Smith MR, Longo DL. Fenton RG, et al. J Natl Cancer Inst. 1993 Aug 18;85(16):1294-302. doi: 10.1093/jnci/85.16.1294. J Natl Cancer Inst. 1993. PMID: 8340941

8

Dose-related immunologic effects of levamisole in patients with cancer.

Janik J, Kopp WC, Smith JW 2nd, Longo DL, Alvord WG, Sharfman WH, Fenton RG, Sznol M, Steis RG, Creekmore SP, et al. Janik J, et al. Among authors: fenton rg. J Clin Oncol. 1993 Jan;11(1):125-35. doi: 10.1200/JCO.1993.11.1.125. J Clin Oncol. 1993. PMID: 8418223 Clinical Trial.

9

Phosphatidylinositol-3-kinase activity is required for the anti-ig-mediated growth inhibition of a human B-lymphoma cell line.

Beckwith M, Fenton RG, Katona IM, Longo DL. Beckwith M, et al. Among authors: fenton rg. Blood. 1996 Jan 1;87(1):202-10. Blood. 1996. PMID: 8547643 Free article.

10

Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma.

Esteva-Lorenzo FJ, Janik JE, Fenton RG, Emslie-Smith A, Engel AG, Longo DL. Esteva-Lorenzo FJ, et al. Among authors: fenton rg. Cancer. 1995 Oct 1;76(7):1219-23. doi: 10.1002/1097-0142(19951001)76:7<1219::aid-cncr2820760719>3.0.co;2-o. Cancer. 1995. PMID: 8630901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page